Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)

Leukemia

Volumn 11, Issue 2, 1997, Pages 294-298

  Preudhomme, C ^a,b   Henic, N ^a,b   Cazin, B ^a   Lai J L ^a   Bertheas, M F ^c   Vanrumbeke, M ^a,b   Lemoine, F ^d   Jouet, J P ^a   Deconninck, E ^e   Nelken, B ^a   Cosson, A ^a   Fenaux, P ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Acute lymphoblastic leukemia; BCR ABL; Philadelphia chromosome (Ph1)

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; BCR ABL PROTEIN; MESSENGER RNA; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RECURRENCE; CLINICAL ARTICLE; CYTOGENETICS; HUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 16944365948     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400567     Document Type: Article

References (14)

1. Preudhomme C, Fenaux P, Laï JL, Lepelley P, Sartiaux C, Collyn-d'Hooghe M, Zañdecki M, Cosson A, Jouet JP, Kerckaert JP. Philadelphia-negative, BCR-ABL-positive adult acute lymphoblastic leukemia (ALL) in two of 39 patients with combined cytogenetic and molecular analysis. Leukemia 1993; 7: 1054-1057.
2. Westbrook CA, Hooberman AL, Spino C, Dodge DK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762). Blood 1992; 80: 2983-2990.
3. Seeker-Walker LM, Craig JM. Prognostic implications of break-point and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review. Leukemia 1993; 7: 147-154.
4. Maurer J, Janssen JWG, Thiel E, Van Denderen J, Ludwig WD, Aydemir Ü, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by polymerase chain reaction. Lancet 1991; 337: 1055-1058.
5. Seeker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV. Philadelphia-positive acute lymphoblastic leukemia in adults age distribution, BCR breakpoint and prognostic significance. Leukemia 1991; 5: 196-199.
6. Preudhomme C, Wattel E, Laï JL, Henic N, Meyer L, Noel MP, Cosson A, Jouet JP, Fenaux P. Good predictive value of combined cytogenetic and molecular follow-up in chronic myelogenous leukemia after non-T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases. Leuk Lymphoma 1995; 18: 265-271.
7. Hughes TP, Morgan GJ, Martial P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874-878.
8. Guerrasio A, Martinelli G, Saglio G, Rosso C, Zaccaria A, Rosti G, Testoni N, Ambrosetti A, Izzi T, Sessarego M, Frassoni F, Gasparini P, Chiamenti A, Di Bartolomeo P, Pignatti PF. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants. Leukemia 1992; 6: 507-512.
9. Delfau MH, Kerckaert JP, Collyn d'Hooghe M, Fenáux P, Laï JL, Jouet JP, Grandchamp B. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990; 4: 1-5.
10. Gaiger A, Lion T, Kalhs P, Mitterbauer G, Henn T, Haas O, Fodinger M, Kier P, Forstinger C, Quehenberger P, Hinterberger W, Jager U, Linkesch W, Mannhalter C, Lechner K. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). Leukemia 1993; 7: 1766-1772.
11. Mitterbauer G, Födinger M, Scherrer R, Knöbl P, Jager U, Laczika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H, Kalhs P, Linkesch W, Lechner K, Mannhalter C. PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL positive acute lymphoblastic leukaemia. Br J Haematol 1995; 89: 937-941.
12. Miyamura K, Tanimoto M, Morishima Y, Horibe K, Yamamoto K, Akatsuka M, Modera Y, Kojima S, Matsuyama K, Hirabayashi N, Yazaki M, Imai K, Onozawa Y, Kanamuru A, Mizutani S, Saito H. Detection of Philadelphia-chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood 1992; 79: 1366-1370.
13. Ifrah N, Harousseau JL, Jouet JP, Desablens B, Linassier C, Guyotat D, Witz F, Babin A, Briere J, Lamy T, Sadoun A, Pignon B, Flesch M, Caillot D, Abgrall JF, Casassus P, Mignard D, Danel P, Boasson M. Traitement intensif avec autogreffe précoce dans les LAL de l'adulte. Nouv Rev Fr Hematol 1993; 35: 334 (Abstr.).
14. Van Rhee F, Marks Dl, Lin F, Szydlo RM, Hochhaus A, Treleaven J, Delord C, Cross NCP, Goldman JM. Quantification of residual disease in Philadelphia positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Leukemia 1995; 9: 329-335.